RhumbLine Advisers’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.57M Buy
267,314
+2,070
+0.8% +$35.4K ﹤0.01% 1458
2025
Q1
$16.9M Sell
265,244
-2,689
-1% -$172K 0.02% 773
2024
Q4
$32.6M Sell
267,933
-2,939
-1% -$357K 0.03% 479
2024
Q3
$33.8M Sell
270,872
-69
-0% -$8.62K 0.03% 467
2024
Q2
$42.8M Buy
270,941
+160,942
+146% +$25.4M 0.04% 368
2024
Q1
$14.2M Sell
109,999
-8,473
-7% -$1.1M 0.01% 872
2023
Q4
$11.4M Sell
118,472
-4,379
-4% -$422K 0.01% 985
2023
Q3
$14.9M Sell
122,851
-1,011
-0.8% -$123K 0.02% 782
2023
Q2
$14.2M Buy
123,862
+16,657
+16% +$1.91M 0.02% 830
2023
Q1
$14.8M Buy
107,205
+6,377
+6% +$879K 0.02% 767
2022
Q4
$13.1M Buy
100,828
+6,975
+7% +$904K 0.02% 801
2022
Q3
$10.4M Buy
93,853
+5,634
+6% +$623K 0.02% 876
2022
Q2
$6.61M Buy
88,219
+9,947
+13% +$746K 0.01% 1105
2022
Q1
$6.12M Sell
78,272
-3,212
-4% -$251K 0.01% 1195
2021
Q4
$7.34M Buy
81,484
+7,717
+10% +$695K 0.01% 1156
2021
Q3
$6.82M Sell
73,767
-474
-0.6% -$43.8K 0.01% 1166
2021
Q2
$5.77M Sell
74,241
-4,101
-5% -$319K 0.01% 1351
2021
Q1
$5.84M Sell
78,342
-5,736
-7% -$428K 0.01% 1324
2020
Q4
$14.3M Sell
84,078
-1,828
-2% -$312K 0.02% 714
2020
Q3
$12.1M Sell
85,906
-3,019
-3% -$424K 0.02% 676
2020
Q2
$14.3M Buy
88,925
+14,599
+20% +$2.34M 0.02% 598
2020
Q1
$7.27M Sell
74,326
-352
-0.5% -$34.4K 0.02% 815
2019
Q4
$9.64M Buy
74,678
+2,675
+4% +$345K 0.02% 855
2019
Q3
$5.42M Sell
72,003
-644
-0.9% -$48.5K 0.01% 1143
2019
Q2
$11M Buy
72,647
+5,482
+8% +$833K 0.02% 723
2019
Q1
$8.01M Sell
67,165
-872
-1% -$104K 0.02% 891
2018
Q4
$7.43M Sell
68,037
-230
-0.3% -$25.1K 0.02% 868
2018
Q3
$11M Buy
68,267
+935
+1% +$151K 0.02% 642
2018
Q2
$8.9M Buy
67,332
+6,473
+11% +$856K 0.02% 740
2018
Q1
$4.51M Sell
60,859
-683
-1% -$50.6K 0.01% 1108
2017
Q4
$3.42M Sell
61,542
-11,001
-15% -$612K 0.01% 1305
2017
Q3
$3.29M Buy
72,543
+11,081
+18% +$503K 0.01% 1292
2017
Q2
$2.07M Buy
61,462
+1,383
+2% +$46.6K ﹤0.01% 1560
2017
Q1
$1.78M Buy
60,079
+2,082
+4% +$61.6K ﹤0.01% 1629
2016
Q4
$1.59M Buy
57,997
+10,323
+22% +$283K ﹤0.01% 1588
2016
Q3
$2.93M Buy
47,674
+955
+2% +$58.7K 0.01% 1169
2016
Q2
$891K Buy
46,719
+721
+2% +$13.8K ﹤0.01% 1860
2016
Q1
$898K Sell
45,998
-1,730
-4% -$33.8K ﹤0.01% 1862
2015
Q4
$1.84M Buy
47,728
+6,615
+16% +$255K 0.01% 1413
2015
Q3
$1.32M Buy
41,113
+1,601
+4% +$51.4K ﹤0.01% 1609
2015
Q2
$1.2M Sell
39,512
-1,845
-4% -$56.1K ﹤0.01% 1749
2015
Q1
$549K Buy
41,357
+7,475
+22% +$99.2K ﹤0.01% 2249
2014
Q4
$490K Sell
33,882
-1,150
-3% -$16.6K ﹤0.01% 2288
2014
Q3
$739K Sell
35,032
-3,665
-9% -$77.3K ﹤0.01% 1967
2014
Q2
$1.15M Buy
38,697
+3,234
+9% +$96.4K ﹤0.01% 1727
2014
Q1
$852K Buy
35,463
+2,240
+7% +$53.8K ﹤0.01% 1903
2013
Q4
$677K Buy
33,223
+1,410
+4% +$28.7K ﹤0.01% 2063
2013
Q3
$1.5M Buy
31,813
+3,653
+13% +$173K ﹤0.01% 1509
2013
Q2
$1.07M Buy
+28,160
New +$1.07M ﹤0.01% 1712